TITLE

Drug Discovery News Headlines May 15, 2003 - June 14, 2003

PUB. DATE
July 2003
SOURCE
PharmaWatch: Biotechnology;July 2003, Vol. 2 Issue 7, p18
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Reports developments in the pharmaceutical industry as of July 2003. Terms of the agreement signed between Amgen Inc. and Tularik Inc.; Partnership between Artesian Therapeutics Inc. and Evotec OAI AG; Introduction of the antibacterial agent developed by CytoGenix Inc.
ACCESSION #
13831841

 

Related Articles

  • Artesian Therapeutics in drug discovery agreement with Evotec OAI.  // PharmaWatch: Biotechnology;July 2003, Vol. 2 Issue 7, p18 

    Focuses on the terms of the agreement signed between Artesian Therapeutics Inc. and Evotec OAI AG in the U.S. Development of drugs used for the treatment of cardiovascular diseases; Enhancement on the quality of service; Use of effective marketing strategies.

  • Amgen and Tularik in oncology collaboration.  // PharmaWatch: Biotechnology;July 2003, Vol. 2 Issue 7, p18 

    Reports on the acquisition of Tularik Inc. by Amgen Inc. in the U.S. Terms of the agreement; Development of various cancer drugs; Amount of funds allotted for several research projects.

  • AMGEN BREAKS OUT OF ITS BOUNDS. Sellers, L.J. // Pharmaceutical Executive;May2004, Vol. 24 Issue 5, p20 

    Reports on biotechnology firm Amgen's acquisition bid for Tularik in the U.S. pharmaceutical industry. Research agreement entered by the two companies in 2003; Nature of Tularik's business; Impact of the proposed deal on Amgen's cancer drug development business.

  • Cardiovascular News Round-Up.  // PharmaWatch: Monthly Review;Nov2009, Vol. 8 Issue 11, p16 

    The article provides updates regarding the developments of various pharmaceutical industries worldwide. Abbott Laboratoties Inc. announced the results from its Prospect clinical trial, the first study to examine the role of plaque in unexpected heart attacks and coronary heart disease. Evotec...

  • EVOTEC OAI/PANACOS TO DEVELOP ANTI-HIV THERAPIES.  // Worldwide Biotech;May2004, Vol. 16 Issue 5, p7 

    Focuses on the medicinal chemistry collaboration between Evotec OAI AG and Panacos Pharmaceuticals Inc. Information on Panacos' clinical trials on PA-457 HIV drug; Business strategy of Evotec; Proprietary discovery technologies of Panacos.

  • Spermatech, Evotec to Screen Target for Male Contraceptive. Sheridan, Cormac // BioWorld International;3/19/2008, Vol. 13 Issue 12, p2 

    The article reports that Evotec AG has been chosen as the partner of Spermatech AS, an early stage Norwegian firm developing a non-hormonal male contraceptive pill, for a high-throughput screening and lead discovery project against a novel target associated with regulating sperm motility. The...

  • Evotec Shares Rise On Kidney Disease Pact with Astrazeneca. Sheridan, Cormac // BioWorld Today;10/23/2013, Vol. 24 Issue 204, p1 

    The article reports that shares in Evotec AG rose 10 percent on October 21, 2013 on news of a research partnership with Astrazeneca plc on the development of disease-modifying drugs for chronic kidney diseases. It informs that while the financial terms were not disclosed, Evotec will receive an...

  • Evotec Gets $15M Up Front In Bayer Endometriosis Pact. Sheridan, Cormac // BioWorld International;10/3/2012, Vol. 17 Issue 40, p1 

    The article announces that Evotec, developer of small molecule drugs, is to receive a total of 12 million Euros up front and 580 million more through a drug discovery alliance with pharmaceutical company Bayer Pharma AG. The drug discovery between the two companies focuses on endometriosis. It...

  • Chemical Efficiency Fragments. May, Mike // Drug Discovery & Development;Aug2007, Vol. 10 Issue 8, p12 

    The article offers world news briefs related to fragmentation in pharmaceutical firms. Evotec AG announces the development of its Innovation Center for Fragmented-Based Drug Discovery with EVOlution screening platform. A partnership is made between Bayer Healthcare AG and Prosteros Biostructures...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics